Lord, Abbett & Co
MYOV

Lord, Abbett & Co’s Myovant Sciences Ltd. MYOV Stock Holding History

Lord, Abbett & Co’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-335,527
Closed -$4.47M – 644
2022
Q1 		$4.47M Sell
335,527
-78,906
-19% -$1.06M 0.01% 556
2021
Q4 		$6.45M Sell
414,433
-113,678
-22% -$2.17M 0.01% 531
2021
Q3 		$11.9M Sell
528,111
-5,908
-1% -$130K 0.03% 502
2021
Q2 		$12.2M Sell
534,019
-1,311,460
-71% -$27.6M 0.03% 503
2021
Q1 		$38M Sell
1,845,479
-15,018
-0.8% -$342K 0.1% 309
2020
Q4 		$51.4M Buy
1,860,497
+35,535
+2% +$692K 0.14% 244
2020
Q3 		$25.6M Buy
1,824,962
+448,739
+33% +$8.35M 0.08% 332
2020
Q2 		$28.4M Sell
1,376,223
-520,137
-27% -$7.08M 0.1% 313
2020
Q1 		$14.3M Buy
1,896,360
+32,960
+2% +$370K 0.06% 373
2019
Q4 		$28.9M Buy
1,863,400
+868,893
+87% +$8.76M 0.1% 329
2019
Q3 		$5.17M Sell
994,507
-979,953
-50% -$7.27M 0.02% 628
2019
Q2 		$17.9M Buy
1,974,460
+8,755
+0.4% +$131K 0.06% 443
2019
Q1 		$46.9M Buy
1,965,705
+52,157
+3% +$1.07M 0.16% 212
2018
Q4 		$31.4M Buy
1,913,548
+16,668
+0.9% +$329K 0.11% 275
2018
Q3 		$50.4M Buy
1,896,880
+734,870
+63% +$16.6M 0.14% 242
2018
Q2 		$26.6M Buy
1,162,010
+1,015,304
+692% +$22.2M 0.08% 401
2018
Q1 		$3.12M Buy
+146,706
New +$2.23M 0.01% 780

Other funds holding MYOV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lord, Abbett & Co's MYOV Position: Q2 2022 in Review

Lord, Abbett & Co sold out of Myovant Sciences Ltd. (MYOV) in Q2 2022, closing a stake of 335,527 shares — an estimated $4.47M sold.

Lord, Abbett & Co first reported a position in MYOV in Q1 2018 and held it in 17 quarters. The position peaked at $51.4M in Q4 2020. 91 funds tracked by Wall St. Rank hold MYOV as of Q2 2022.

  • Lord, Abbett & Co reported no remaining Myovant Sciences Ltd. position as of Q2 2022 after selling out during the quarter.
  • Lord, Abbett & Co sold 335,527 Myovant Sciences Ltd. shares in Q2 2022, an estimated $4.47M.
  • Lord, Abbett & Co first reported a position in Myovant Sciences Ltd. in Q1 2018 and held it in 17 quarters.
  • Lord, Abbett & Co's Myovant Sciences Ltd. position peaked at $51.4M in Q4 2020.
  • 91 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2022.

Based on Lord, Abbett & Co's 13F filing for Q2 2022, filed 12 Aug 2022.